Kamil M. Yenice to Neoplasms
This is a "connection" page, showing publications Kamil M. Yenice has written about Neoplasms.
Connection Strength
0.168
-
ACR-ASTRO Practice Parameter for the Performance of Stereotactic Body Radiation Therapy. Am J Clin Oncol. 2020 08; 43(8):545-552.
Score: 0.065
-
The utility of FDG-PET for assessing outcomes in oligometastatic cancer patients treated with stereotactic body radiotherapy: a cohort study. Radiat Oncol. 2012 Dec 18; 7:216.
Score: 0.038
-
Tumor hypoxia is an important mechanism of radioresistance in hypofractionated radiotherapy and must be considered in the treatment planning process. Med Phys. 2011 Dec; 38(12):6347-50.
Score: 0.036
-
An initial report of a radiation dose-escalation trial in patients with one to five sites of metastatic disease. Clin Cancer Res. 2008 Aug 15; 14(16):5255-9.
Score: 0.028